In controlled clinical trials at a leading medical institution, Pyratine® reduced facial erythema and improved skin roughness in as early as 2 weeks. Adverse effects are minimal and transient!
~ Journal of Drugs in Dermatology
This content is password protected. To view it please enter your password below: